ADAM10 and early-onset autosomal dominant Alzheimer disease: Multiple reviews have been published supporting the potential of ADAM10 protein in platelets and cerebrospinal fluid to serve as a biomarker for Alzheimer's disease diagnoses (82, 136, 137).